ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IDHC Integrated Diagnostics Holdings Plc

0.395
-0.0115 (-2.83%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Integrated Diagnostics Holdings Plc LSE:IDHC London Ordinary Share JE00BLKGSR75 ORD USD0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0115 -2.83% 0.395 0.39 0.40 0.40 0.40 0.40 94 16:35:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Integrated Diagnostics Holdings PLC Notice of Results (7832R)

05/03/2019 7:02am

UK Regulatory


Integrated Diagnostics (LSE:IDHC)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Integrated Diagnostics Charts.

TIDMIDHC

RNS Number : 7832R

Integrated Diagnostics Holdings PLC

05 March 2019

Integrated Diagnostics Holdings Plc

Notice of results

5 March 2019

(London) - Integrated Diagnostics Holdings ("IDH," "the Group," or "the Company"), IDHC on the London Stock Exchange, a leading consumer healthcare company with operations in Egypt, Jordan, Sudan and Nigeria, will publish its results for the year ended 31 December 2018 on Thursday 21 March 2019 at 7am GMT.

An analyst and investor presentation will be hosted at the offices of Hudson Sandler, 25 Charterhouse Square, EC1M 6AE at 2pm GMT on Thursday 21 March 2019. A live audio webcast will be available on the Group's website at www.idhcorp.com.

Please email idh@hudsonsandler.com if you would like to attend the presentation.

Contact

 
 IDH                                    +20 (0)2 3345 5530 
 Sherif El-Ghamrawi,                    +20 (0)10 0447 8699 
  Investor Relations Director            sherif.elghamrawi@idhcorp.com 
 
 Hudson Sandler (International Media 
  relations)                            +44 (0) 207 796 4133 
 Dan de Belder                          idh@hudsonsandler.com 
  Bertie Berger 
 

About Integrated Diagnostics Holdings

IDH is a leading consumer healthcare company in the Middle East and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The Group's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar Sudan (both in Sudan) and Echo-Scan (Nigeria). A long track record for quality and safety has earned the Company a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 1,400 diagnostics tests. From its base of 405 branches as of 30 June 2018, IDH will continue to add laboratories through a Hub, Spoke and Spike business model that provides a scalable platform for efficient expansion. Beyond organic growth, the Group's expansion plans include acquisitions in new Middle Eastern and African markets where its model is well-suited to capitalise on similar healthcare and consumer trends and capture a significant share of fragmented markets. IDH has been a Jersey-registered entity with a Standard Listing on the Main Market of the London Stock Exchange (ticker: IDHC) since May 2015.

IDH's forward-looking strategy rests on leveraging its established business model to achieve four key strategic goals, namely: (1) continue to expand customer reach; (2) increase the number of tests per patient; (3) expand into new geographic markets through selective, value-accretive acquisitions; and (4) introduce new medical services by leveraging the Group's network and reputable brand position. Learn more at idhcorp.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORDMGGFDDMGLZM

(END) Dow Jones Newswires

March 05, 2019 02:02 ET (07:02 GMT)

1 Year Integrated Diagnostics Chart

1 Year Integrated Diagnostics Chart

1 Month Integrated Diagnostics Chart

1 Month Integrated Diagnostics Chart

Your Recent History

Delayed Upgrade Clock